The role of microbiota in allergy

Annales Nestle

Volumn 67, Issue 1, 2009, Pages 19-25

  Kalliomäki, Marko ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Allergy; Asthma; Eczema, atopic; Gut microbiota; Oral tolerance

Indexed keywords

ANTIINFECTIVE AGENT;

AGE DISTRIBUTION; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ALLERGY; ANTIMICROBIAL THERAPY; ARTICLE; ATOPIC DERMATITIS; BACTERIAL FLORA; BIFIDOBACTERIACEAE; CELL FUNCTION; CLINICAL FEATURE; CLOSTRIDIA; CROSS-SECTIONAL STUDY; CULTURE TECHNIQUE; DIETARY INTAKE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; ENVIRONMENTAL SANITATION; ESCHERICHIA COLI; FAMILY SIZE; FOLLOW UP; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INTESTINE; INTESTINE FLORA; MICROBIAL COLONIZATION; NONHUMAN; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; VACCINATION;

EID: 63449093801     PISSN: 05178606     EISSN: 16614011     Source Type: Journal    
DOI: 10.1159/000187166     Document Type: Article

References (57)

1. Johansson SG, Bieber T, Dahl R, et al: Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113: 832-836.
2. Holgate ST: The epidemic of allergy and asthma. Nature 1999; 402(suppl):B2-B4.
3. Flohr C, Weiland SK, Weinmayr G, et al: The role of atopic sensitization in flexural eczema: findings from the international study of asthma and allergies in childhood phase two. J Allergy Clin Immunol 2008; 121: 141-147.
4. Sampson HA, Ho DG: Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol 1997; 100: 444-451.
5. Prescott SL, Macaubas C, Smallacombe T, et al: Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999; 353: 196-200.
6. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). 2007. Available at: http://www.ginasthma.org.
7. Saglani S, Malmström K, Pelkonen AS, et al: Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005; 171: 722-727.
8. Bloemen K, Verstraelen S, Van Vel Heuvel R, et al: The allergic cascade: review of the most important molecules in the asthmatic lung. Immunol Lett 2007; 113: 6-18.
9. Larche M: Regulatory T cells in allergy and asthma. Chest 2007; 132: 1007-1014.
10. Monteleone G, Pallone F, MacDonald TT: Interleukin 21: a critical regulator of the balance between effector and regulatory T cell responses. Trends Immunol 2008; 29: 290-294.
11. Chehade M, Mayer L: Oral tolerance and its relation to food hypersensitivities. J Allergy Clin Immunol 2005; 115: 3-12.
12. Burks W, Laubach S, Jones SM: Oral tolerance, food allergy and immunotherapy: implications for future treatment. J Allergy Clin Immunol 2008; 121: 1344-1350.
13. Beyer K, Castro R, Birnbaum A, et al: Human milk-specific mucosal lymphocytes of the gastrointestinal tract display a TH2 cytokine profile. J Allergy Clin Immunol 2002; 109: 707-713.
14. Perez-Machado MA, Ashwood P, Thomson MA, et al: Reduced transforming growth factor- β1-producing T cells in the duodenal mucosa of children with food allergy. Eur J Immunol 2003; 33: 2307-2315.
15. Karlsson MR, Rugtveig J, Brandtzaeg P: Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 2004; 199: 1679-1688.
16. Sudo N, Sawamura SA, Tanaka K, et al: The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997; 159: 1739-1745.
17. Ostman S, Rask C, Wold AE, et al: Impaired regulatory T cell function in germ-free mice. Eur J Immunol 2006; 36: 2336-2346.
18. Ishikawa H, Tanaka K, Maeda Y, et al: Effect of intestinal microbiota on the induction of regulatory CD4+CD25+ T cells. Clin Exp Immunol 2008; 153: 127-135.
19. Repa A, Kozakova H, Hudcovic T, et al: Susceptibility to nasal and oral tolerance induction to the major birch pollen allergen Bet v 1 is not dependent on the presence of the microflora. Immunol Lett 2008; 117: 50-56.
20. Berg RD: The indigenous gastrointestinal microflora. Trends Microbiol 1996; 4: 430- 435.
21. Tannock GW: What immunologists should know about bacterial communities of the human bowel. Semin Immunol 2007; 19: 94-105.
22. Peterson DA, Frank DN, Pace NR, Gordon JI: Metagenomic approaches to defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 2008; 3: 417-427.
23. Zoetendal EG, Collier CT, Koike S, et al: Molecular ecological analysis of the gastrointestinal microbiota: a review. J Nutr 2004; 134: 465-472.
24. Palmer C, Bik EM, DiGiulio DB, et al: Development of the human infant intestinal microbiota. PLoS Biol 2007; 5: 1556-1573.
25. Penders J, Thijs C, Vink C, et al: Factors influencing the composition of the intestinal microbiota during the first year of life. Pediatrics 2006; 118: 511-521.
26. Strachan DP: Hay fever, hygiene, and household size. BMJ 1989; 299: 1259-1260.
27. Alm JS, Swartz J, Lilja G, et al: Atopy in children of families with an anthroposophic lifestyle. Lancet 1999; 353: 1485-1488.
28. Flöistrup H, Swartz J, Bergström A, et al: Allergic disease and sensitization in Steiner school children. J Allergy Clin Immunol 2006; 117: 59-66.
29. Schaub B, Lauener R, von Mutius E: The many faces of the hygiene hypothesis. J Allergy Clin Immunol 2008; 117: 969-977.
30. Ege MJ, Frei R, Bieli C, et al: Not all farming environments protect against the development of asthma and wheeze in children. J Allergy Clin Immunol 2007; 119: 1140-1147.
31. Alm JS, Swartz J, Björksten B, et al: An anthroposophic lifestyle and intestinal microflora in infancy. Pediatr Allergy Immunol 2002; 13: 402-411.
32. Dicksved J, Flöistrup H, Bergström A, et al: Molecular fingerprinting of children raised according to different lifestyles. Appl Environ Microbiol 2007; 73: 2284-2289.
33. Rautava S, Ruuskanen O, Ouwehand A, et al: The hygiene hypothesis of atopic disease - an extended version. J Pediatr Gastroenterol Nutr 2004; 39: 529-535.
34. Björksten B, Naaber P, Sepp E, Mikelsaar M: The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999; 29: 342-346.
35. Kirjavainen PV, Apostolou E, Arvola T, et al: Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol 2001; 32: 1-7.
36. Ouwehand AC, Isolauri E, He F, et al: Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol 2001; 108: 144-145.
37. Böttcher MF, Nordin EK, Sandin A, et al: Microflora- associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy 2000; 30: 1590-1596.
38. Watanabe S, Narisawa Y, Arase S, et al: Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol 2003; 111: 587-591.
39. Matsumoto M, Kakizoe K, Benno Y: Comparison of fecal microbiota and polyamine concentration in adult patients with intractable atopic dermatitis and healthy adults. Microbiol Immunol 2007; 51: 37-46.
40. Mah KW, Björksten B, Lee BW, et al: Distinct pattern of commensal gut microbiota in toddlers with eczema. Int Arch Allergy Immunol 2006; 140: 157-163.
41. Woodcock A, Moradi M, Smillie FI, et al: Clostridium difficile , atopy and wheeze during the first year of life. Pediatr Allergy Immunol 2002; 13: 357-360.
42. Murray CS, Tannock GW, Simon MA, et al: Fecal microbiota in sensitized wheezy and non-sensitized non-wheezy children: a nested case-control study. Clin Exp Allergy 2005; 35: 741-745.
43. Linneberg A, Ostergaard C, Tvede M, et al: IgG antibodies against microorganisms and atopic disease in Danish adults: the Copenhagen Allergy Study. J Allergy Clin Immunol 2003; 111: 847-853.
44. Fukuda S, Ishikawa H, Koga Y, et al: Allergic symptoms and microflora in schoolchildren. J Adolesc Health 2004; 35: 156-158.
45. Sepp E, Julge K, Mikelsaar M, Björksten B: Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy 2005; 35: 1141-1146.
46. Kendler M, Uter W, Rueffer A, et al: Comparison of fecal microflora in children with atopic eczema/dermatitis syndrome according to IgE sensitization to food. Pediatr Allergy Immunol 2006; 17: 141-147.
47. Gore C, Munro K, Lay C, et al: Bifidobacterium pseudocatenulatum is associated with atopic eczema: a nested case-control study investigating the fecal microbiota of infants. J Allergy Clin Immunol 2008; 121: 135-140.
48. Stsepetova J, Sepp E, Julge K, et al: Molecularly assessed shifts of Bifidobacterium ssp. and less diverse microbial communities are characteristic of 5-year-old allergic children. FEMS Immunol Med Microbiol 2007; 51: 60-269.
49. Penders J, Stobberingh EE, van den Brandt PA, Thijs C: The role of the intestinal microbiota in the development of atopic disorders. Allergy 2007; 62: 1223-1236.
50. Kalliomäki M, Kirjavainen P, Eerola E, et al: Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107: 129-134.
51. Björksten B, Sepp E, Julge K, et al: Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001; 1084: 516-520.
52. Penders J, Thijs C, van den Brandt PA, et al: Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 2007; 56: 661-667.
53. Penders J, Stobberingh E, Thijs C, et al: Molecular fingerprinting of the intestinal microbiota of infants in whom atopic eczema was or was not developing. Clin Exp Allergy 2006; 36: 1602-1608.
54. Adlerberth I, Strachan DP, Matricardi PM, et al: Gut microbiota and development of atopic eczema in 3 European birth cohorts. J Allergy Clin Immunol 2007; 120: 343-350.
55. Wang M, Karlsson C, Olsson C, et al: Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol 2008; 121: 129-134.
56. Prescott SL, Björksten B: Probiotics for the prevention or treatment of allergic diseases. J Allergy Clin Immunol 2007; 120: 255-262.
57. Palmer CNA, Irvine AD, Terron-Kwiatkowski A, et al: Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-446.